Shares of Acadia Healthcare Co. (NASDAQ:ACHC) have earned an average recommendation of “Buy” from the fifteen analysts that are currently covering the stock. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $75.00.
Several research firms recently commented on ACHC. Robert W. Baird reiterated an “outperform” rating and set a $69.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, June 14th. Royal Bank Of Canada reduced their price objective on shares of Acadia Healthcare from $86.00 to $78.00 and set an “outperform” rating for the company in a research note on Monday, August 1st. Jefferies Group reiterated a “buy” rating and set a $85.00 price objective on shares of Acadia Healthcare in a research note on Monday, June 27th. Zacks Investment Research lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 11th. Finally, Leerink Swann restated an “outperform” rating and set a $90.00 price target on shares of Acadia Healthcare in a research note on Friday, July 15th.
Shares of Acadia Healthcare (NASDAQ:ACHC) traded down 2.21% on Tuesday, hitting $46.39. 390,363 shares of the stock traded hands. The company has a market cap of $4.06 billion, a PE ratio of 24.78 and a beta of 0.86. The stock has a 50 day moving average of $50.18 and a 200 day moving average of $54.96. Acadia Healthcare has a one year low of $45.85 and a one year high of $74.77.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Friday, July 29th. The company reported $0.73 EPS for the quarter, hitting the consensus estimate of $0.73. The firm earned $756.50 million during the quarter, compared to analyst estimates of $752.57 million. Acadia Healthcare had a net margin of 6.44% and a return on equity of 9.35%. Acadia Healthcare’s revenue was up 66.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.57 EPS. Equities analysts anticipate that Acadia Healthcare will post $2.63 earnings per share for the current year.
In related news, CFO David M. Duckworth sold 16,670 shares of the stock in a transaction on Monday, August 15th. The shares were sold at an average price of $54.33, for a total transaction of $905,681.10. Following the sale, the chief financial officer now directly owns 11,688 shares of the company’s stock, valued at $635,009.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Waud Capital Partners Iii, L.L sold 457,443 shares of the stock in a transaction on Friday, September 16th. The stock was sold at an average price of $48.39, for a total transaction of $22,135,666.77. The disclosure for this sale can be found here. Corporate insiders own 17.20% of the company’s stock.
Hedge funds have recently made changes to their positions in the company. Advisory Services Network LLC increased its stake in shares of Acadia Healthcare by 5,542.1% in the third quarter. Advisory Services Network LLC now owns 2,144 shares of the company’s stock worth $106,000 after buying an additional 2,106 shares during the period. American International Group Inc. increased its position in Acadia Healthcare by 71.7% in the second quarter. American International Group Inc. now owns 2,218 shares of the company’s stock valued at $123,000 after buying an additional 926 shares during the last quarter. Advisor Group Inc. bought a new position in Acadia Healthcare during the second quarter valued at about $166,000. Springbok Capital Management LLC increased its position in Acadia Healthcare by 101.3% in the first quarter. Springbok Capital Management LLC now owns 3,741 shares of the company’s stock valued at $206,000 after buying an additional 1,883 shares during the last quarter. Finally, Jane Street Group LLC bought a new position in Acadia Healthcare during the second quarter valued at about $210,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Receive News & Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.